News

“We want to help individuals with cancer receive the best imaging possible,” says Matt Covington, MD. Dr. Covington is a radiologist at Huntsman Cancer Institute who specializes in cancer imaging. In this letter of hope, he explains why he is passionate about his research and how advances in cancer imaging can help patients today and in the future.

Douglas Sborov, MD, MS, discusses the work being done by the multiple myeloma and clinical trials programs at Huntsman Cancer Institute. He also shares why this work is so meaningful and how a Robin Williams character resonates with him in this latest Talks with Docs.

“The gift that clinical trial participation gives—not only to science but to our patients—should not be limited by language,” says Sadie Gabler, director of the University of Utah Office of Research Participant Advocacy. She explains why clinical trial translation and interpretation services are a crucial part of the effort to reduce health disparities.

Amyloidosis is a rare disease and researchers are trying to find new treatments for the disease. Huntsman Cancer Institute's Amandeep Godara, MBBS, tells you more about the disease, including its causes, symptoms and possible treatments.

A cyclotron manufactures radiopharmaceuticals for positron emission tomography (PET) scans, which help doctors see where cancer is located inside the body. Huntsman Cancer Institute director of cyclotron operations, Brandon Buckway, explains how the cyclotron is a crucial tool in treating people with cancer.

Max Rosett faced melanoma as a young adult and a decade later, he is cancer free. He describes how he felt after being diagnosed, the outstanding treatment he received at Huntsman Cancer Institute and the revolutionary immunotherapy clinical trials that helped save his life.

Adriana Coletta, PhD, MS, RD, discusses the amazing new work being done for metastatic prostate cancer patients, what the future of exercise cancer research could look like, and her violin skills in the latest Talks with Docs.

Huntsman Cancer Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, and the SWOG CLL Study S1925, or EVOLVE CLL, an international study evaluating a new approach to chronic lymphocytic leukemia or small lymphocytic lymphoma.